Background: Dinitrosyl nonheme-iron complexes can appear in cells and tissues overproducing nitric oxide. It is believed that due to their chemical nature these species may be implicated in certain pathophysiological events. We studied the possible role of low molecular mass dinitrosyl iron complexes in the control of noradrenaline release in electrically stimulated rat tail artery.
Background
Dinitrosyl non-heme iron complexes (DNIC) are intrinsic nitric oxide (NO)-derived species that can appear in various NO overproducing tissues including inflammatory blood vessels [1, 2] . Due to their reactivity, DNIC may have multiple biologically important targets. [3] [4] [5] [6] [7] [8] . There are high molecular mass (protein-bound) and low molecular mass DNIC, paramagnetic and diamagnetic DNIC [9] . The low molecular mass DNIC are much more powerful nitrosative agents than NO or the low molecular weight S-nitrosothiols [5, 9] . Depending on the micro-environment, DNIC can provide at least two types of nitrosative modification of proteins, forming either protein-Snitrosothiols or protein-bound dinitrosyl iron complexes [5, 9] . Under certain conditions, low molecular mass DNIC may also serve as NO donors and consequently as activators of soluble guanylyl cyclase and vasodilators [7] . Nitrosative modification of proteins can lead to a change of protein function and may have important physiological significance [8, [10] [11] [12] . We have demonstrated recently, that in neuronal/neurosecretory PC 12 cells, low molecular mass DNIC specifically activate non-selective cationic channels and induce membrane depolarisation [6] . We hypothesised, that low molecular mass DNIC may also affect the process of neuromediator release, which is known to be associated with membrane depolarisation and involves an array of thiol-containing proteins which are usually sensitive to S-nitrosation [13, 14] . To test this hypothesis, we used the model of the electrical field stimulated rat tail artery in which neither constitutive NO nor the NO donor SIN-1, influence the release of noradrenaline [15] . Here we demonstrate for the first time, that the two model compounds, DNIC-thiosulfate and DNICcysteine up-regulate noradrenaline release in the rat tail artery.
Results
Low molecular mass DNIC increase [ 3 H]noradrenaline release DNIC-thiosulfate (1-10 µM), in a concentration dependent manner, enhanced the electrical field stimulated [ 3 H] noradrenaline release. This effect showed significance already at 3 µM DNIC-thiosulfate (Fig. 1) . In the same arteries, DNIC-thiosulfate inhibited the stimulation-evoked vasoconstriction (Fig 1) , consistent with its NO donor properties. DNIC-cysteine (at 3 µM) reproduced both these effects (Table 1) . "The false complex", Fe(II)-thiosulfate (10 µM) did not affect either [ 3 H]noradrenaline release or neurogenic vasoconstriction ( Table 1) . The conventional NO and NO+ donors, sodium nitroprusside (SNP), S-nitroso-L-cysteine (Cys-NO) and S-nitroso-glutathione (GS-NO) (at 10 µM) potently inhibited the neurogenic vasoconstriction, had however no effect on 
Cyclic GMP-dependent protein kinase does not play a role
The membrane permeable and metabolically stable competitive inhibitor of cyclic GMP-dependent protein kinase (PKG), Rp-8pCPT-cGMPS (10 µM), did not change the electrical field stimulated [ 3 H]noradrenaline release and vasoconstriction in control arteries (Fig. 2) . Rp-8pCPT-cGMPS did not affect the augmentation of [ 3 H]noradrenaline release caused by DNIC-thiosulfate. At the same time, Rp-8pCPT-cGMPS, partially but significantly reduced the "NO-dependent" inhibitory effect of DNIC-thiosulfate on vasoconstriction (Fig 2) .
Discussion
The major finding of the present study is that DNIC-thiosulfate and DNIC-cysteine, at low micromolar concentrations, stimulate the electrical field-evoked noradrenaline release in the rat tail artery, while other NO and NO+ donors at these concentrations lack this ability.
During the past 10 years, NO has been recognised as a local neuromediator of the central and peripheral nervous system [16] . The role of NO in the process of noradrenaline release in vascular tissue is largely contradictory [17] [18] [19] [20] . The contradiction of these results could be in part due to the involvement of different NO-related species in different experimental models. The interactions of NO with transitional metals control the reactivity of NO including nitrosation and/or nitration of different biological targets. DNIC, bound to different ligands is an example of such an NO-metal interaction [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . Recently, we have shown that in neuronal/neurosecretory PC 12 cells, DNIC-thiosulfate specifically activates a depolarising cationic inward current; the mechanism of this activation is cyclic GMPindependent and involves an attachment of dinitrosyl- iron moieties to yet unknown protein(s) of the plasma membrane [6] . To test whether DNIC could affect the neuromediator release, we here used the model of the electrically stimulated rat tail artery. An advantage of this model is that vasoactive concentrations of NO or cyclic GMP analogues have no effect on the noradrenaline release [15, 21] . Thus, the potential NO-dependent effect of DNIC on noradrenaline release in this model is likely excluded. Accordingly, in the present study, the conventional NO donors, SNP, Cys-NO and GS-NO, markedly inhibited neurogenic vasoconstriction, but did not affect the release of noradrenaline. In contrast, both DNIC-thiosulfate and DNIC-cysteine were found to be quite potent stimulators of the electrically evoked noradrenaline release.
While the mechanism of the augmentation of noradrenaline release by the low molecular mass DNIC requires further investigations, it is clearly NO/cyclic GMP/PKGindependent. Because our experiments were performed in the presence of cocaine and since DNIC had no effect on the basal noradrenaline release, the possible modification of tissue noradrenaline uptake seems to be excluded. The process of neuromediator release is an extremely complex cellular action, which is known to involve several cysteine-rich proteins [13] . Thus, it is possible that, in analogy with other thiol-containing proteins [10] [11] [12] , the function of these proteins is sensitive to S-nitrosative modification. Since low molecular mass DNIC were shown to be much more potent S-nitrosative agents than low molecular mass S-nitrosothiols and NO [5] , this scenario appears to be very likely. The potential role of oxygen radicals and lipid peroxidation in the DNIC action are less probable since the "false complex", Fe(II)-thiosulfate, which can accelerate the formation of oxygen radicals, showed no effect. Moreover, various iron-heme-NO and iron-nonheme-NO complexes proved to be strong antioxidants [22] .
In this study a rather discouraging result was the lack of an apparent contractile effect of the noradrenaline released by DNIC. This could be attributed to the limitations of our experimental model, especially to the intra-luminary manner of DNIC supply and to the highly oxygenated conditions favouring oxidation of iron in DNIC and liberation of NO [23] . Thus, it is likely that in our model, NOmediated vasodilation masked the vasoconstriction, which is expected from the DNIC-induced increase of noradrenaline release. Previously, we have observed a similar phenomenon using forskolin, which also produced vasodilation despite a marked stimulatory effect on the release of noradrenaline [24] . Nevertheless, we believe that our findings are not only a curious pharmacological phenomenon, but also may be of pathophysiological importance. It is likely, that the loci of endogenous DNIC formation could be critical for the functional net result of DNIC action. Of note, DNIC species are not as easily diffusible as free NO, thus a concentration gradient in cells/ tissues could be expected.
The concentration of protein-bound DNIC (which is in equilibrium with low molecular mass DNIC) in inflammatory tissue may be as high as 100 µM [5] . Since low molecular weight DNIC have a pronounced effect on noradrenaline release already at low micromolar concentrations, the present findings may have pathophysiological implications. Recently, the tunica adventitia and its potential impact on blood vessel function attracted much attention [25] . Specifically in endotoxin-exposed rat aorta, the adventitia was recognised as the major site of inducible NO synthase expression and DNIC production [2] . Thus, in the inflammatory blood vessels, the generation of DNIC may occur in close proximity to (or even within) the sympathetic nerve endings. Therefore, one can speculate that DNIC, under these circumstances, may unexpectedly contribute to vascular contraction. Additionally, because catecholamines are known to have a trophic effect on the vascular wall [26] , the DNIC-mediated increase of noradrenaline release may contribute to the thickening of inflammatory blood vessels. A recent study in patients with coronary artery disease suggests, that chelatable nonheme iron interacts with endothelial NO and thus contributes to endothelial dysfunction [27] . Whether this interaction results in the generation of DNIC-like complexes, which in turn may affect the release of catecholamines, is an intriguing question.
Conclusion
Low molecular mass iron dinitrosyl complexes augment the electrical field-stimulated release of [ 3 H]noradrenaline in the rat tail artery. This activity discriminates irondinitrosyl complexes from conventional NO donors and is apparently NO independent. This finding may have important implications for inflammatory tissues with nonheme-iron dinitrosyl species formation.
Materials and Methods

Experimental protocol
A detailed description of the methodology was reported previously [15] . Briefly, male Wistar rats (12 weeks old) were killed by cervical dislocation and exsanguinated. A segment (2-2.5 cm long) of the proximal part of the ventral tail artery was dissected out and kept in oxygenated (95% O 2 /5%CO 2 ) medium consisting of (in mM): NaCl 118, KCl 4. 
